Fingerprint
Dive into the research topics of 'Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
TRANSFORM Investigators
Research output: Contribution to journal › Article › peer-review